Cost-analysis of management strategies for children with vesicoureteric reflux

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 88, Issue 431, 1999, Pages 79-86

  Nicklasson, L ^a,b   Hojgard S ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Children; Cost analysis; Direct costs; Indirect costs; Vesico ureteric reflux

Indexed keywords

ANTIBIOTIC AGENT; TRIMETHOPRIM;

ANTIBIOTIC PROPHYLAXIS; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DRUG COST; ENDOSCOPIC THERAPY; HEALTH CARE COST; HOSPITAL COST; HUMAN; PRIORITY JOURNAL; SWEDEN; URETER REIMPLANTATION; URINARY TRACT INFECTION; VESICOURETERAL REFLUX;

EID: 0032731888     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1999.tb01322.x     Document Type: Conference Paper

References (8)

1. 1. Lindgren B, Costs of illness in Sweden 1964-1975. Lund Economic Studies. Dissertation, 1981
2. 2. Jacobson L, Lindgren B. Astma. De samhällsekonomiska kostnaderna. (Asthma. The social costs). Studier i hälsoekonomi 8 (Studies in Health Economics 8). Reprocentralen. Lunds Universitet, 1995
3. 3. Drummond M, Stoddart G, Torrance G. Methods for the economic evaluation of health care programmes. Oxford Medical Publications. Oxford: Oxford University Press, 1987
4. 4. Sugden R, Williams A. The principles of practical cost-benefit analysis. Oxford: Oxford University Press, 1978
5. 5. Lindgren B. Health care in Sweden. In: Alban A, Christiansen T, editors. The Nordic Lights. New initiatives in health care systems. Odense: Odense University Press, 1995
6. 6. Statistics Sweden. The Income Distribution Study (Inkomstfördelningsundersokningen) Be20 SM9501, Statistics Sweden, 1995.
7. 7. Statistics Sweden. The Labour Force Study (arbetskraftsundersökningarna, AKU). Statistics Sweden, fourth quarter, 1995
8. 8. Leonard M, Decter A, Mix L, Johnson H, Coleman G. Endoscopic treatment of vesicoureteral reflux with collagen: preliminary report and cost analysis. J Urol 1996; 155: 1716-20